[The calcipotriol-betamethasone dipropionate association].
F Henry, C Flagothier, P Delvoye, C Piérard-Franchimont, G E Piérard
Index: Rev. Med. Liege. 60(11) , 893-5, (2005)
Full Text: HTML
Abstract
The topical treatment of psoriasis benefits from the alternate use of dermocorticosteroids and vitamin D3 analogues. A new galenic formulation allows to combine them in a single application. Dovobet (LEO Pharma) ointment is the association of calcipotriol 50 microg/g with betamethasone dipoprionate 0.5 mg/g. This formulation boosts the therapeutic activity of calcipotriol. It also decreases the irritative inflammatory reaction due to calcipotriol without increasing the atrophogenic risk of the dermocorticoid.
Related Compounds
Related Articles:
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2009-01-01
[Bioorg. Med. Chem. 17 , 896-904, (2009)]
Developing structure-activity relationships for the prediction of hepatotoxicity.
2010-07-19
[Chem. Res. Toxicol. 23 , 1215-22, (2010)]
A predictive ligand-based Bayesian model for human drug-induced liver injury.
2010-12-01
[Drug Metab. Dispos. 38 , 2302-8, (2010)]
Chemical genetics reveals a complex functional ground state of neural stem cells.
2007-05-01
[Nat. Chem. Biol. 3(5) , 268-273, (2007)]